Home > Insider Trading > Filing (0000874015-17-000013)

Filing Details

Accession Number:: 0000874015-17-000013
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-01-18 18:36:45
Reporting Period:: 2017-01-15

Filing Date:: 2017-01-18
Accepted Time:: 2017-01-18 18:36:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874015	Ionis Pharmaceuticals Inc	IONS	Pharmaceutical Preparations (2834)	330336973

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
897667	T Stanley Crooke	C/O Ionis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010	Chairman And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-01-15	5,547	$0.00	30,576	No	4	M	Direct
Common Stock	Disposition	2017-01-17	3,008	$46.29	27,568	No	4	S	Direct
Common Stock	Acquisiton	2017-01-15	7,812	$0.00	35,380	No	4	M	Direct
Common Stock	Disposition	2017-01-17	4,236	$46.29	31,144	No	4	S	Direct
Common Stock	Acquisiton	2017-01-15	6,875	$0.00	38,019	No	4	M	Direct
Common Stock	Disposition	2017-01-17	3,728	$46.29	34,291	No	4	S	Direct
Common Stock	Acquisiton	2017-01-15	8,133	$0.00	42,424	No	4	M	Direct
Common Stock	Disposition	2017-01-17	4,410	$46.29	38,014	No	4	S	Direct
Common Stock	Acquisiton	2017-01-15	416	$0.00	2,586	No	4	M	Indirect	By wife
Common Stock	Disposition	2017-01-17	163	$46.29	2,423	No	4	S	Indirect	By wife
Common Stock	Acquisiton	2017-01-15	354	$0.00	2,777	No	4	M	Indirect	By wife
Common Stock	Disposition	2017-01-17	139	$46.29	2,638	No	4	S	Indirect	By wife
Common Stock	Acquisiton	2017-01-15	363	$0.00	3,001	No	4	M	Indirect	By wife
Common Stock	Disposition	2017-01-17	142	$46.29	2,859	No	4	S	Indirect	By wife
Common Stock	Acquisiton	2017-01-15	334	$0.00	3,193	No	4	M	Indirect	By wife
Common Stock	Disposition	2017-01-17	131	$46.29	3,062	No	4	S	Indirect	By wife

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Indirect	By wife
No	4	S	Indirect	By wife
No	4	M	Indirect	By wife
No	4	S	Indirect	By wife
No	4	M	Indirect	By wife
No	4	S	Indirect	By wife
No	4	M	Indirect	By wife
No	4	S	Indirect	By wife

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Acquisiton	2017-01-15	27,168	$0.00	27,168	$0.00
Common Stock	Restricted Stock Units	Acquisiton	2017-01-15	2,692	$0.00	2,692	$0.00
Common Stock	Restricted Stock Units	Disposition	2017-01-15	5,547	$0.00	5,547	$0.00
Common Stock	Restricted Stock Units	Disposition	2017-01-15	7,812	$0.00	7,812	$0.00
Common Stock	Restricted Stock Units	Disposition	2017-01-15	6,875	$0.00	6,875	$0.00
Common Stock	Restricted Stock Units	Disposition	2017-01-15	8,133	$0.00	8,133	$0.00
Common Stock	Restricted Stock Units	Disposition	2017-01-15	416	$0.00	416	$0.00
Common Stock	Restricted Stock Units	Disposition	2017-01-15	354	$0.00	354	$0.00
Common Stock	Restricted Stock Units	Disposition	2017-01-15	363	$0.00	363	$0.00
Common Stock	Restricted Stock Units	Disposition	2017-01-15	334	$0.00	334	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
27,168	No	4	A	Direct
2,692	No	4	A	Indirect
0	No	4	M	Direct
7,812	No	4	M	Direct
13,750	No	4	M	Direct
24,397	No	4	M	Direct
0	No	4	M	Indirect
354	No	4	M	Indirect
724	No	4	M	Indirect
999	No	4	M	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	725,391	Indirect	By trust

Footnotes

Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 30, 2013.
The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 30, 2013.
Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2014.
The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2014.
Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2015.
The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2015.
Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2016.
The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2016.
Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2013.
The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2013.
Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
Grant 1/15/2017 to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on January 15, 2018. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2021. The RSU is vested as to 0 shares on January 15, 2017.
Grant 1/15/2017 to reporting person's wife of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on January 15, 2018. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2021. The RSU is vested as to 0 shares on January 15, 2017.
Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.